Zhejiang Jiankang Biotechnology Co., Ltd. is a wholly-owned subsidiary of Zhejiang Jiankang Group. As the production base of Jiankang Group*, it has centralized the Nanjing factory, Hangzhou factory, and Jiaxing factory into Binhai New City for unified production and sales. Established in December 2018 with a total investment of 60 million yuan, it specializes in producing intelligent POCT instrument series and IVD in vitro diagnostic reagent series products. It has 4 POCT production lines and 14 reagent production lines. The company is designed to produce 100,000 units (sets) of POCT and 600 million doses of IVD in vitro diagnostic reagents annually, and hopes to achieve a production and sales capacity of 1 billion after 5 years. At present, it has obtained medical approval documents and production licenses for 8 nationally exclusive innovative products. It is currently preparing for large-scale production and sales. The current epidemic prevention product, the novel coronavirus detection kit, has obtained the EU CE certificate and has been listed on the whitelist of the website of the China Chamber of Commerce for Import and Export of Medicines and Health Products. The company is in the early stage of preparations for mass production.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows